Equibles does not estimate personal net worth.
Get an email with a short summary when Revolution Medicines, Inc. publishes a filing, an earnings call transcript or a press release.
Get RVMD alertsRyan Asay has spoken on 3 earnings calls and 1 other investor event across 1 company, most recently for Revolution Medicines, Inc. on August 5, 2026. Revolution Medicines, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Revolution Medicines, Inc. includes Mark Goldsmith (CEO and Board Member), Jack Anders (CFO), Margaret Horn (COO) and 7 others.
“Joining me on today's call are Dr. Mark Goldsmith, Revolution Medicine's Chairman and Chief Executive Officer, Dr. Alan Sandler, our Chief Development Officer, and Jack Anders, our Chief Financial Officer.”
“Joining me on today's call are Dr. Mark Goldsmith, Revolution Medicine's Chairman and Chief Executive Officer, and Dr. Ray Lin, our Chief Medical Officer.”
“Joining me on today's call are Dr. Mark Goldsmith, Revolution Medicine's Chairman and Chief Executive Officer, Dr. Alan Sandler, our Chief Development Officer, and Jack Anders, our Chief Financial Officer.”
“Joining me on today's call are Dr. Mark Goldsmith, our Chairman and Chief Executive Officer, and Jack Anders, our Chief Financial Officer. Dr. Steve Kelsey, our President of Research and Development.”
Source not stated
Biotechnology · Healthcare
